Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Income from Continuing Operations (2016 - 2018)

Armata Pharmaceuticals' Income from Continuing Operations history spans 6 years, with the latest figure at 1101000.0 for Q4 2018.

  • For Q4 2018, Income from Continuing Operations fell 122.68% year-over-year to 1101000.0; the TTM value through Dec 2018 reached 9977000.0, down 73.63%, while the annual FY2024 figure was 53178000.0, 22.71% down from the prior year.
  • Income from Continuing Operations for Q4 2018 was 1101000.0 at Armata Pharmaceuticals, up from 2771000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 4854000.0 in Q4 2017 and bottomed at 11307000.0 in Q1 2014.
  • The 5-year median for Income from Continuing Operations is 2910500.0 (2018), against an average of 3161944.44.
  • The largest annual shift saw Income from Continuing Operations plummeted 691.25% in 2014 before it skyrocketed 231.26% in 2017.
  • A 5-year view of Income from Continuing Operations shows it stood at 2597000.0 in 2014, then rose by 6.51% to 2428000.0 in 2015, then crashed by 52.31% to 3698000.0 in 2016, then surged by 231.26% to 4854000.0 in 2017, then crashed by 122.68% to 1101000.0 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Income from Continuing Operations are 1101000.0 (Q4 2018), 2771000.0 (Q3 2018), and 3050000.0 (Q2 2018).